Improvements in treatment have helped cut cancer death rates in half; rates fell an average of 2.1% per year between 2002 and 2004, twice the decline of the previous five years.
Washington, D.C. (November 30, 2006) — Seventy-seven new medicines and vaccines are in development to treat HIV/AIDS and related conditions, according to a survey released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).
Researchers Are Testing 77 Medicines and Vaccines For HIV and Opportunistic Infections
HIV/AIDS is one of the world’s most devastating diseases. To help fight it, biopharmaceutical researchers are testing 77 medicines for HIV/AIDS and related conditions and intensifying their work toward the development of vaccines. The medicines now in the pipeline will add to the 88 already approved since the AIDS virus was first identified more than 20 years ago.
Новини
